IBIO

IBIO INC

IBIO·451033708·US·Common Stock·Healthcare - Biotechnology-13D/G

IBIO (IBIO INC) is held by 30 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($3.7M), Ensign Peak Advisors, Inc ($3.2M), Woodline Partners LP ($3.1M). Net institutional sentiment: Mixed.

30
Holders
(1 Elite)
$26.5M
Total Value
66% (35)
Consensus
23 buying - 12 selling
13F: Insider & Congress: Updated regularly
IBIO

Smart Money Verdict

View all
Loading verdict
Held by 30 funds
1 elite

Who's Trading

Source dates: Price Oct 14, 2026 · Insiders Mar 27, 2026 · Activists Oct 14, 2026 · Congress none

ActivistCOCoastlands Capital LP9.7%Oct 14, 2026
ActivistLYLynx1 Capital Management LP5.4%Aug 14, 2026
ActivistCACormorant Asset Management, LP10.0%Aug 14, 2026
Checking access…

Top Holders

Checking access…
Action
Increased
2.1M(+92.8%)$3.7M0.0%-65.06%
42
New
1.8M$3.2M0.0%-55.33%
37
New
1.8M$3.1M0.0%-55.33%
37
Increased
1.7M(+6.6%)$2.9M0.0%-70.30%
28
Increased
1.4M(+44.7%)$2.4M0.0%-67.42%
35
Increased
1.2M(+15.8%)$2M0.0%-54.14%
30
Increased
1.1M(+286.2%)$2M0.0%—
42
Increased
904,132(+45.7%)$1.6M0.0%—
35
Increased
500,816(+29.2%)$876,6500.0%—
21
Increased
500,375(+28.8%)$875,6560.0%—
31
New
498,872$873,0260.0%-55.33%
34
Decreased
400,667(-2.0%)$701,1670.0%-54.28%
0
Increased
286,875(+39.9%)$502,0310.0%-67.72%
32
Increased
242,016(+84.4%)$423,5280.0%—
25
New
202,847$354,9820.0%-55.33%
33
Increased
200,455(+0.1%)$350,7960.0%-70.92%
16
Increased
170,799(+21.0%)$298,8980.0%—
19
Increased
111,319(+44.0%)$194,8080.0%—
21
Decreased
57,842(-7.4%)$101,2240.0%—
0
New
10,637$18,6140.0%-55.33%
28

Showing 1-20 of 36

1 / 2
IBIOIBIOIBIO INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used